Methods and compositions for the treatment of pancreatic cancer
作者： Thorsten Hagemann
DOI:
关键词:
摘要: A composition comprising a TLR2 antagonistic antibody or antigen binding fragment thereof for use in the treatment prophylaxis of pancreatic cancer is provided. The may be provided simultaneous, separate sequential administration with secondary chemotherapeutic agent such as gemcitabine, and optionally tertiary abraxane enhanced treatment. Also screening method identification compounds prevention cancer.
lens.org参考文章(19)
J. Thomas Ngo, Joe Marks, Martin Karplus, Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox The Protein Folding Problem and Tertiary Structure Prediction. pp. 433- 506 ,(1994) , 10.1007/978-1-4684-6831-1_14
Olivier Leger, Greg Elson, Combining therapies targeting multiple toll-like receptors and use thereof ,(2005)
Guangxun Meng, Hermann Wagner, Carsten Juergen Kirschning, TLR2 antagonistic antibody and use thereof ,(2004)
Jerome Dellacasagrande, Humanised antibodies to Toll-like receptor 2 and uses thereof ,(2010)
Graham Donnelly, Mark Heffernan, Christopher Locher, William Mccormack, Toll-like receptor binding epitope and compositions for binding thereto ,(2008)
Peer Bork, Amos Bairoch, Go hunting in sequence databases but watch out for the traps Trends in Genetics. ,vol. 12, pp. 425- 427 ,(1996) , 10.1016/0168-9525(96)60040-7
P. Bork, Powers and pitfalls in sequence analysis: the 70% hurdle. Genome Research. ,vol. 10, pp. 398- 400 ,(2000) , 10.1101/GR.10.4.398
Evelina Miele, Gian Paolo Spinelli, Ermanno Miele, Federica Tomao, Silverio Tomao, Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. International Journal of Nanomedicine. ,vol. 4, pp. 99- 105 ,(2009) , 10.2147/IJN.S3061
James A. Wells, Additivity of mutational effects in proteins Biochemistry. ,vol. 29, pp. 8509- 8517 ,(1990) , 10.1021/BI00489A001
Temple F. Smith, Xiaolin Zhang, The challenges of genome sequence annotation or "the devil is in the details". Nature Biotechnology. ,vol. 15, pp. 1222- 1223 ,(1997) , 10.1038/NBT1197-1222